Cargando…
Multivalent vaccines against new SARS-CoV-2 hybrid variants
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969532/ http://dx.doi.org/10.1016/j.vacune.2023.02.007 |
_version_ | 1784897754433060864 |
---|---|
author | Ghazvini, Kiarash Keikha, Masoud |
author_facet | Ghazvini, Kiarash Keikha, Masoud |
author_sort | Ghazvini, Kiarash |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9969532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99695322023-02-27 Multivalent vaccines against new SARS-CoV-2 hybrid variants Ghazvini, Kiarash Keikha, Masoud Vacunas (English Edition) Carta al Director Elsevier España, S.L.U. 2023 2023-02-27 /pmc/articles/PMC9969532/ http://dx.doi.org/10.1016/j.vacune.2023.02.007 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Carta al Director Ghazvini, Kiarash Keikha, Masoud Multivalent vaccines against new SARS-CoV-2 hybrid variants |
title | Multivalent vaccines against new SARS-CoV-2 hybrid variants |
title_full | Multivalent vaccines against new SARS-CoV-2 hybrid variants |
title_fullStr | Multivalent vaccines against new SARS-CoV-2 hybrid variants |
title_full_unstemmed | Multivalent vaccines against new SARS-CoV-2 hybrid variants |
title_short | Multivalent vaccines against new SARS-CoV-2 hybrid variants |
title_sort | multivalent vaccines against new sars-cov-2 hybrid variants |
topic | Carta al Director |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969532/ http://dx.doi.org/10.1016/j.vacune.2023.02.007 |
work_keys_str_mv | AT ghazvinikiarash multivalentvaccinesagainstnewsarscov2hybridvariants AT keikhamasoud multivalentvaccinesagainstnewsarscov2hybridvariants |